Improved survival of patients with myelofibrosis in the last decade: Single‐center experience

Patterns of Care for Older Patients With Myelofibrosis: A Population-based Study

(2021) Shelby Meckstroth et al.   Clinical Lymphoma Myeloma & Leukemia

Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval

(2021) Srdan Verstovsek et al.   ANNALS OF HEMATOLOGY

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

(2019) Natasha Szuber et al.   MAYO CLINIC PROCEEDINGS

Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group

(2019) Barbara Mora et al.   AMERICAN JOURNAL OF HEMATOLOGY

MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

(2018) Ayalew Tefferi et al.   JOURNAL OF CLINICAL ONCOLOGY

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

(2018) Ayalew Tefferi et al.   LEUKEMIA

Prefibrotic myelofibrosis: treatment algorithm 2018

(2018) Guido Finazzi et al.   Blood Cancer Journal

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

(2017) F Passamonti et al.   LEUKEMIA

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis

(2017) Lucia Masarova et al.   LEUKEMIA RESEARCH

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12

(2016) Samer A. Srour et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies

(2016) A. A. Zahr et al.   HAEMATOLOGICA

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies

(2016) A. A. Zahr et al.   HAEMATOLOGICA

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

(2015) A. M. Vannucchi et al.   HAEMATOLOGICA

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

(2015) N M Kröger et al.   LEUKEMIA

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

(2015) A. M. Vannucchi et al.   HAEMATOLOGICA

Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring

(2013) R. Luthra et al.   HAEMATOLOGICA

Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls

(2012) S. Verstovsek et al.   BLOOD

Improving Survival Trends in Primary Myelofibrosis: An International Study

(2012) Francisco Cervantes et al.   JOURNAL OF CLINICAL ONCOLOGY

Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study

(2012) Malin Hultcrantz et al.   JOURNAL OF CLINICAL ONCOLOGY

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

(2010) Naseema Gangat et al.   JOURNAL OF CLINICAL ONCOLOGY

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

(2010) D Caramazza et al.   LEUKEMIA

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains in Recent Years

(2009) Rakhee Vaidya et al.   MAYO CLINIC PROCEEDINGS

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

(2008) F Cervantes et al.   LEUKEMIA